Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Menveo solution for injection - UK EMC Drug Approval Details

Approvals/UK EMC/Menveo solution for injection

Approved

STANDARD

Menveo solution for injection

GlaxoSmithKline UK🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: e64e4a4329d86354
Company: GlaxoSmithKline UK
Type: Standard

Approval Details

Approval Id: e64e4a4329d86354
Drug Approval Emc Name: Menveo solution for injection
Drug Name: Menveo solution for injection
Company Name: GlaxoSmithKline UK
Company Address: 79 New Oxford Street, London, WC1A 1DG, UK
Company Telephone: 0800 221 441
Company Medical Info Email: [email protected]
Atc Code: J07AH08
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

e64e4a4329d86354

Type

Standard

Back to UK EMC Approvals